Convergent translational evidence of a role for anandamide in amygdala-mediated fear extinction, threat processing and stress-reactivity

Molecular Psychiatry

Volumn 18, Issue 7, 2013, Pages 813-823

  Gunduz Cinar, O ^a,b   MacPherson, K P ^a   Cinar, R ^a   Gamble George, J ^c   Sugden, K ^d,e,f   Williams, B ^d,e,f   Godlewski, G ^a   Ramikie, T S ^c   Gorka, A X ^d   Alapafuja, S O ^g   Nikas, S P ^g   Makriyannis, A ^g   Poulton, R ^h   Patel, S ^c   Hariri, A R ^d,e   Caspi, A ^d,e,f   Moffitt, T E ^d,e,f   Kunos, G ^a   Holmes, A ^a  

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d DUKE UNIVERSITY   (United States)

^e DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f KING'S COLLEGE LONDON   (United Kingdom)

^g NORTHEASTERN UNIVERSITY   (United States)

^h UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

amygdala; anxiety; cannabinoid; fear; gene; stress

Indexed keywords

AM 3506; ANANDAMIDE; CANNABINOID 1 RECEPTOR ANTAGONIST; FATTY ACID AMIDASE; FATTY ACID AMIDASE INHIBITOR; UNCLASSIFIED DRUG;

ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BASOLATERAL AMYGDALA; CONTROLLED STUDY; FEAR; GENE EXPRESSION; GENETIC VARIABILITY; HABITUATION; LATERAL AMYGDALA; LOCOMOTION; LONG TERM DEPRESSION; MOUSE; NERVE CELL PLASTICITY; NONHUMAN; PERSONALITY; PRIORITY JOURNAL; STRESS; SYSTEMIC THERAPY; THREAT;

ADAPTATION, PSYCHOLOGICAL; ADULT; ALKANESULFONATES; AMIDOHYDROLASES; AMYGDALA; ANIMALS; ARACHIDONIC ACIDS; CANNABINOID RECEPTOR ANTAGONISTS; CONDITIONING (PSYCHOLOGY); ENDOCANNABINOIDS; ENZYME INHIBITORS; EXTINCTION, PSYCHOLOGICAL; FEAR; FEMALE; FUNCTIONAL NEUROIMAGING; GENETIC ASSOCIATION STUDIES; HABITUATION, PSYCHOPHYSIOLOGIC; HUMANS; MALE; MICE; MICROINJECTIONS; MIDDLE AGED; NEURONAL PLASTICITY; PERSONALITY; PHENOLS; PIPERIDINES; POLYMORPHISM, SINGLE NUCLEOTIDE; POLYUNSATURATED ALKAMIDES; PYRAZOLES;

EID: 84879412059     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2012.72     Document Type: Article

References (58)

1. Cryan JF, Holmes A. The ascent of mouse: advances in modelling human depression and anxiety. Nat Rev Drug Discov 2005; 4: 775-790.
2. Quirk GJ, Pare D, Richardson R, Herry C, Monfils MH, Schiller D et al. Erasing fear memories with extinction training. J Neurosci 2010; 30: 14993-14997.
3. Marsicano G, Wotjak CT, Azad SC, Bisogno T, Rammes G, Cascio MG et al. The endogenous cannabinoid system controls extinction of aversive memories. Nature 2002; 418: 530-534.
4. Kamprath K, Marsicano G, Tang J, Monory K, Bisogno T, Di Marzo V et al. Cannabinoid CB1 receptor mediates fear extinction via habituation-like processes. J Neurosci 2006; 26: 6677-6686.
5. Herkenham M, Lynn AB, Little MD, Johnson MR, Melvin LS, de Costa BR et al. Canna-binoid receptor localization in brain. Proc Natl Acad Sci USA 1990; 87: 1932-1936.
6. Kathuria S, Gaetani S, Fegley D, Valino F, Duranti A, Tontini A et al. Modulation of anxiety through blockade of anandamide hydrolysis. Nat Med 2003; 9: 76-81.
7. Marsicano G, Lutz B. Neuromodulatory functions of the endocannabinoid system. J Endocrinol Invest 2006; 29: 27-46.
8. Cravatt BF, Lichtman AH. Fatty acid amide hydrolase: an emerging therapeutic target in the endocannabinoid system. Curr Opin Chem Biol 2003; 7: 469-475.
9. de Oliveira Alvares L, Pasqualini Genro B, Diehl F, Molina VA, Quillfeldt JA. Opposite action of hippocampal CB1 receptors in memory reconsolidation and extinction. Neuroscience 2008; 154: 1648-1655.
10. Kinsey SG, Long JZ, Cravatt BF, Lichtman AH. Fatty acid amide hydrolase and monoacylglycerol lipase inhibitors produce anti-allodynic effects in mice through distinct cannabinoid receptor mechanisms. J Pain 2010; 11: 1420-1428.
11. Spradley JM, Guindon J, Hohmann AG. Inhibitors of monoacylglycerol lipase, fatty-acid amide hydrolase and endocannabinoid transport differentially suppress capsaicin-induced behavioral sensitization through peripheral endocannabinoid mechanisms. Pharmacol Res 2010; 62: 249-258.
12. Schlosburg JE, Blankman JL, Long JZ, Nomura DK, Pan B, Kinsey SG et al. Chronic monoacylglycerol lipase blockade causes functional antagonism of the endo-cannabinoid system. Nat Neurosci 2010; 13: 1113-1119.
13. Quirk GJ, Mueller D. Neural mechanisms of extinction learning and retrieval. Neuropsychopharmacology 2008; 33: 56-72.
14. Herry C, Ferraguti F, Singewald N, Letzkus JJ, Ehrlich I, Luthi A. Neuronal circuits of fear extinction. Eur J Neurosci 2010; 31: 599-612.
15. Varvel SA, Wise LE, Niyuhire F, Cravatt BF, Lichtman AH. Inhibition of fatty-acid amide hydrolase accelerates acquisition and extinction rates in a spatial memory task. Neuropsychopharmacology 2007; 32: 1032-1041.
16. Hajos N, Kathuria S, Dinh T, Piomelli D, Freund TF. Endocannabinoid transport tightly controls 2-arachidonoyl glycerol actions in the hippocampus: effects of low temperature and the transport inhibitor AM404. Eur J Neurosci 2004; 19: 2991-2996.
17. Tan H, Lauzon NM, Bishop SF, Chi N, Bechard M, Laviolette SR. Cannabinoid transmission in the basolateral amygdala modulates fear memory formation via functional inputs to the prelimbic cortex. J Neurosci 2011; 31: 5300-5312.
18. Chhatwal JP, Davis M, Maguschak KA, Ressler KJ. Enhancing cannabinoid neurotransmission augments the extinction of conditioned fear. Neuropsycho-pharmacology 2005; 30: 516-524.
19. Godlewski G, Alapafuja SO, Batkai S, Nikas SP, Cinar R, Offertaler L et al. Inhibitor of fatty acid amide hydrolase normalizes cardiovascular function in hypertension without adverse metabolic effects. Chem Biol 2010; 17: 1256-1266.
20. Bashashati M, Storr MA, Nikas SP, Wood JT, Godlewski G, Liu J et al. Inhibiting fatty acid amide hydrolase normalizes endotoxin-induced enhanced gastrointestinal motility in mice. Br J Pharmacol 2012; 165: 1556-1571.
21. Fowler CJ, Tiger G, Stenstrom A. Ibuprofen inhibits rat brain deamidation of anandamide at pharmacologically relevant concentrations. Mode of inhibition and structure-activity relationship. J Pharmacol Exp Ther 1997; 283: 729-734.
22. Dinh TP, Carpenter D, Leslie FM, Freund TF, Katona I, Sensi SL et al. Brain monoglyceride lipase participating in endocannabinoid inactivation. Proc Natl Acad Sci USA 2002; 99: 10819-10824.
23. Hefner K, Whittle N, Juhasz J, Norcross M, Karlsson RM, Saksida LM et al. Impaired fear extinction learning and cortico-amygdala circuit abnormalities in a common genetic mouse strain. J Neurosci 2008; 28: 8074-8085.
24. Whittle N, Hauschild M, Lubec G, Holmes A, Singewald N. Rescue of impaired fear extinction and normalization of cortico-amygdala circuit dysfunction in a genetic mouse model by dietary zinc restriction. J Neurosci 2010; 30: 13586-13596.
25. Camp M, MacPherson KP, Lederle L, Graybeal C, Gaburro S, DeBrouse L et al. Genetic strain differences in learned fear inhibition associate with variation in neuroendocrine, autonomic and amygdala dendritic phenotypes. Neuropsycho-pharmacology 2012; 37: 1534-1547.
26. Brigman JL, Wright T, Talani G, Prasad-Mulcare S, Jinde S, Seabold GK et al. Loss of GluN2B-containing NMDA receptors in CA1 hippocampus and cortex impairs long-term depression, reduces dendritic spine density, and disrupts learning. J Neurosci 2010; 30: 4590-4600.
27. Yang RJ, Mozhui K, Karlsson RM, Cameron HA, Williams RW, Holmes A. Variation in mouse basolateral amygdala volume is associated with differences in stress reactivity and fear learning. Neuropsychopharmacology 2008; 33: 2595-2604.
28. Wellman CL, Izquierdo A, Garret JE, Martin KP, Carroll J, Millstein R et al. Impaired stress-coping and fear extinction and abnormal corticolimbic morphology in serotonin transporter knock-out mice. J Neurosci 2007; 27: 684-691.
29. Wiedholz LM, Owens WA, Horton RE, Feyder M, Karlsson RM, Hefner K et al. Mice lacking the AMPA GluR1 receptor exhibit striatal hyperdopaminergia and 'schizophrenia-related' behaviors. Mol Psychiatry 2008; 13: 631-640.
30. Cryan JF, Markou A, Lucki I. Assessing antidepressant activity in rodents: recent developments and future needs. Trends Pharmacol Sci 2002; 23: 238-245.
31. Norcross M, Mathur P, Enoch AJ, Karlsson RM, Brigman JL, Cameron HA et al. Effects of adolescent fluoxetine treatment on fear-, anxiety-or stress-related behaviors in C57BL/6J or BALB/cJ mice. Psychopharmacology (Berl) 2008; 200: 413-424.
32. Bellocchio L, Lafenetre P, Cannich A, Cota D, Puente N, Grandes P et al. Bimodal control of stimulated food intake by the endocannabinoid system. Nat Neurosci 2010; 13: 281-283.
33. Mukhopadhyay B, Cinar R, Yin S, Liu J, Tam J, Godlewski G et al. Hyperactivation of anandamide synthesis and regulation of cell-cycle progression via cannabinoid type 1 (CB1) receptors in the regenerating liver. Proc Natl Acad Sci USA 2011; 108: 6323-6328.
34. Patel S, Kingsley PJ, Mackie K, Marnett LJ, Winder DG. Repeated homotypic stress elevates 2-arachidonoylglycerol levels and enhances short-term endocannabinoid signaling at inhibitory synapses in basolateral amygdala. Neuropsychopharmacol-ogy 2009; 34: 2699-2709.
35. Lafourcade M, Elezgarai I, Mato S, Bakiri Y, Grandes P, Manzoni OJ. Molecular components and functions of the endocannabinoid system in mouse prefrontal cortex. PLoS One 2007; 2: e709.
36. Wang W, Sun D, Pan B, Roberts CJ, Sun X, Hillard CJ et al. Deficiency in endocannabinoid signaling in the nucleus accumbens induced by chronic unpredictable stress. Neuropsychopharmacology 2010; 35: 2249-2261.
37. First M, Spitzer R, Gibbon M, Williams J. Structured Clinical Interview for DSM-IV Axis I Disorders, Research Version, Non-Patient Edition. New York State Psychiatric Institute, Biometrics Research Department: New York, 1996.
38. Brown SM, Manuck SB, Flory JD, Hariri AR. Neural basis of individual differences in impulsivity: contributions of corticolimbic circuits for behavioral arousal and control. Emotion 2006; 6: 239-245.
39. Brown SM, Peet E, Manuck SB, Williamson DE, Dahl RE, Ferrell RE et al. A regulatory variant of the human tryptophan hydroxylase-2 gene biases amygdala reactivity. Mol Psychiatry 2005; 10: 884-888, 805.
40. Manuck SB, Brown SM, Forbes EE, Hariri AR. Temporal stability of individual differences in amygdala reactivity. Am J Psychiatry 2007; 164: 1613-1614.
41. Ekman P, Friesen W. Pictures of Facial Affect. Consulting Psychologists Press: Palo Alto, CA, 1976.
42. Viviani R. Unbiased ROI selection in neuroimaging studies of individual differences. NeuroImage 2010; 50: 184-189.
43. Sipe JC, Chiang K, Gerber AL, Beutler E, Cravatt BF. A missense mutation in human fatty acid amide hydrolase associated with problem drug use. Proc Natl Acad Sci USA 2002; 99: 8394-8399.
44. Chiang KP, Gerber AL, Sipe JC, Cravatt BF. Reduced cellular expression and activity of the P129T mutant of human fatty acid amide hydrolase: evidence for a link between defects in the endocannabinoid system and problem drug use. Hum Mol Genet 2004; 13: 2113-2119.
45. Flanagan JM, Gerber AL, Cadet JL, Beutler E, Sipe JC. The fatty acid amide hydrolase 385 A/A (P129T) variant: haplotype analysis of an ancient missense mutation and validation of risk for drug addiction. Hum Genet 2006; 120: 581-588.
46. Hariri AR, Gorka A, Hyde LW, Kimak M, Halder I, Ducci F et al. Divergent effects of genetic variation in endocannabinoid signaling on human threat-and reward-related brain function. Biol Psychiatry 2009; 66: 9-16.
47. Patrick CJ, Curtin JJ, Tellegen A. Development and validation of a brief form of the multidimensional personality questionnaire. Psychol Assess 2002; 14: 150-163.
48. Holmes A, Quirk GJ. Pharmacological facilitation of fear extinction and the search for adjunct treatments for anxiety disorders-the case of yohimbine. Trends Pharmacol Sci 2010; 31: 2-7.
49. Kamprath K, Romo-Parra H, Haring M, Gaburro S, Doengi M, Lutz B et al. Short-term adaptation of conditioned fear responses through endocannabinoid signaling in the central amygdala. Neuropsychopharmacology 2011; 36: 652-663.
50. Plendl W, Wotjak CT. Dissociation of within-and between-session extinction of conditioned fear. J Neurosci 2010; 30: 4990-4998.
51. Pamplona FA, Bitencourt RM, Takahashi RN. Short-and long-term effects of cannabinoids on the extinction of contextual fear memory in rats. Neurobiol Learn Mem 2008; 90: 290-293.
52. Riebe CJ, Pamplona F, Kamprath K, Wotjak CT. Fear relief-toward a new conceptual frame work and what endocannabinoids gotta do with it. Neuroscience 2012; 204: 159-185.
53. Lin HC, Mao SC, Su CL, Gean PW. The role of prefrontal cortex CB1 receptors in the modulation of fear memory. Cereb Cortex 2009; 19: 165-175.
54. Ehrlich I, Humeau Y, Grenier F, Ciocchi S, Herry C, Luthi A. Amygdala inhibitory circuits and the control of fear memory. Neuron 2009; 62: 757-771.
55. Chevaleyre V, Heifets BD, Kaeser PS, Sudhof TC, Castillo PE. Endocannabinoid-mediated long-term plasticity requires cAMP/PKA signaling and RIM1alpha. Neuron 2007; 54: 801-812.
56. Azad SC, Monory K, Marsicano G, Cravatt BF, Lutz B, Zieglgansberger W et al. Circuitry for associative plasticity in the amygdala involves endocannabinoid signaling. J Neurosci 2004; 24: 9953-9961.
57. Krueger RF, Caspi A, Moffitt TE. Epidemiological personology: the unifying role of personality in population-based research on problem behaviors. J Pers 2000; 68: 967-998.
58. Miller MW. Personality and the etiology and expression of PTSD. Clin Psychol Sci Pract 2003; 10: 373-393.